Pentasa and pericardial effusion Patient Reports February 12, 2012

Pentasa Side Effects Report #4655911-9
Pentasa side effect was reported by a Consumer or non-health professional from on Apr 21, 2005. Male patient, 59 years of age, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: diarrhoea, pericardial effusion, vomiting. Pentasa dosage: unknown. During the same period patient was treated with OMEPRAZOLE, CILAZAPRIL, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5370591-5
Pentasa side effect was reported by a Health Professional from FRANCE on June 08, 2007. Female patient, 36 years of age, was diagnosed with crohn's disease , hypothyroidism and was treated with Pentasa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthralgia, cardiac failure, chest pain , hepatomegaly, inflammation, lymphocyte percentage increased, pericardial effusion, pleural effusion. Pentasa dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, REMICADE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5372830-3
Pentasa side effect was reported by a Consumer or non-health professional from FRANCE on June 12, 2007. Female patient, 36 years of age, was diagnosed with crohn's disease , hypothyroidism and was treated with Pentasa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthralgia, chest pain , hepatomegaly, pericardial effusion, pericarditis, pleural effusion, right ventricular failure. Pentasa dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, REMICADE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5199851-8
Pentasa side effect was reported by a Consumer or non-health professional from FRANCE on Dec 15, 2006. Male patient, 77 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: brain natriuretic peptide increased, c-reactive protein increased, dyspnoea exertional, fibrin d dimer increased, intracardiac mass, intracardiac thrombus, pericardial effusion, platelet count decreased, treatment noncompliance. Pentasa dosage: 2000 MG DAILY, ORAL. During the same period patient was treated with RAMIPRIL, BISOPROLOL, AMLODIPINE BESYLATE, FUROSEMIDE, LANSOPRAZOLE, ALENDRONATE, ACETYLSLICYLATE LYSINE, PREDNISOLONE SULFOBENZOATE. Patient was hospitalized. Patient recovered.


Pentasa Side Effects Report #4571115-2
Pentasa side effect was reported by a Health Professional from on Jan 20, 2005. Male patient, 59 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: asthenia, hypersensitivity, hypotension, pericardial effusion, pleural effusion, pyrexia, rash , tachycardia. Pentasa dosage: 2000 MG, DAILY, ORAL. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4724276-6
Pentasa side effect was reported by a Health Professional from FRANCE on July 11, 2005. Male patient, 59 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: hypersensitivity, pericardial effusion, pleural effusion. Pentasa dosage: 2000 MG, DAILY, ORAL. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5124931-2
Pentasa side effect was reported by a Consumer or non-health professional from JAPAN on Sept 22, 2006. Female patient, 31 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: cough, pericardial effusion, pericarditis, pharyngolaryngeal pain, pleural effusion, pleurisy, pyrexia. Pentasa dosage: 750 MG, 3X/DAY; TID; ORAL. During the same period patient was treated with CEFAMEZIN, CEFDINIR. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5574115-9
Pentasa side effect was reported by a Physician from JAPAN on Dec 10, 2007. Female patient, 19 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: pericardial effusion. Pentasa dosage: 1000 MG, 3X/DAY; TID, ORAL; 2250 MG DAILY, ORAL. During the same period patient was treated with RABEPRAZOLE. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4889708-1
Pentasa side effect was reported by a Consumer or non-health professional from SWITZERLAND on Jan 06, 2006. Male patient was diagnosed with colitis ulcerative, rhinitis and was treated with Pentasa. After drug was administered, patient experienced the following side effects: foetal disorder, pericardial effusion, tachycardia foetal, urinary tract malformation. Pentasa dosage: unknown. During the same period patient was treated with ASACOL, TRIOFAN. Patient recovered.


Pentasa Side Effects Report #5353606-X
Pentasa side effect was reported by a Health Professional from FRANCE on May 24, 2007. Female patient, 36 years of age, was diagnosed with hypothyroidism, crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthralgia, hepatomegaly, pericardial effusion, pleural effusion, right ventricular failure. Pentasa dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, REMICADE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5330631-6
Pentasa side effect was reported by a Health Professional from NORWAY on Apr 26, 2007. Male patient, child 12 years of age, was treated with Pentasa. After drug was administered, patient experienced the following side effects: pericardial effusion. Pentasa dosage: unknown. During the same period patient was treated with ASACOL. Patient recovered.